Skip to Content

Seminar Series

The Rolanette and Berdon Lawrence Bone Disease Program of Texas presents monthly seminars given by internationally recognized scientists working in the field of skeletal biology.

Unless otherwise noted, lectures are held on the first Friday of each month, 1:30 - 2:30 p.m, at MD Anderson Cancer Center in the AT&T Telehealth Center, room FC1.2002 of the Faculty Center Building, 1400 Holcombe Blvd., Houston, Texas. Directions and Map (pdf).

2013-2014 Bone Seminar Series

Sept. 6, 2013Rulang Jiang, Ph.D.,
Professor, Division of Developmental Biology
Cincinnati Children's Hospital
Cincinnati, Ohio
The Genetic control of Craniofacial Development of Patterning
Oct. 2013No speakers for this month (2 November speakers instead) 
Nov. 1, 2013Alex Robling, Ph.D.,
Associate Professor of Anatomy and Cell Biology
Indiana University School of Medicine
Indianapolis, IN
Therapeutic Applications of Wnt Signaling to Bone Metabolic Disorders
Nov. 22, 2013TBDTBD
Dec. 6, 2013David Ornitz, M.D., Ph.D.,
Alumni Endowed Professor, Department of Developmental Biology,
Washington University School of Medicine,
St Louis, Missouri
Fibroclast Growth Factor Signaling Pathways in Skeletal Development
Jan. 3, 2014Daniel Bikle, M.D., Ph.D.,
Professor, Departments of Medicine and Dermatology,
University of California at San Francisco,
San Francisco, CA
The Critical Role of IGF-I Signaling During Bone Development and Remodeling.
Feb. 7, 2014Brian Foster, Ph.D.,
Postdoctoral Fellow,
NIAMS Laboratory of Oral Connective Tissue Biology,
Bethesda, Maryland
Key Regulators of Mineralization in Periodontal Development and Regeneration
Mar. 7, 2014Janet Rubin, M.D.,
Professor, Division of Endocrinology/Metabolism,
Department of Medicine,
University of North Carolina at Chapel Hill,
Chapel Hill, NC
Dynamic Mechanical Environment Regulates Mesenchymal Stem Cell Differentiation
April 4, 2014Robert Lindsay, M.D., Ph.D.,
Professor of Clinical Medicine, Chief of Osteoporisis Center,
Helen Hayes Hospital,
New York, NY
Osteoporosis- Where are We Going?
May 2, 2014John Bilezikian, M.D.,
Professor of Medicine and Pharmacology,
Columbia University,
New York, NY
Primary Hyperparathyroidism: New Insights, Concepts and Guidelines for 2014.

For more information, contact Lea Tatar at 713-792-1345 or

© 2014 The University of Texas MD Anderson Cancer Center